References
- Hadler S C. Global impact of hepatitis A virus infection: changing patterns. Viral hepatitis and liver diseases, F B Hollinger, S M Lemon, H S Margolis. Williams & Wilkins, Baltimore 1991; 14–20
- Gust I D. Epidemiological patterns of hepatitis A in different parts of the world. Vaccine 1992; 10(Suppl 1)S56–8
- Briem H. Declining prevalence of antibodies to hepatitis A virus infection in Iceland. Scand J Infectious Dis 1991; 23: 135–8
- Papaevangelou G. Epidemiology of hepatitis A in Mediterranean countries. Vaccine 1992; 10(Suppl 1)S63–6
- Routenberg J A, Dienstag G L, Harrison W O, Kilpatrick M E, Hooper R R, Chisari F V, et al. Foodborne outbreak of hepatitis A: clinical and laboratory features of acute and protracted illness. Am J Med Sci 1979; 278: 123–37
- Jacobson I M, Nath B J, Dienstag J L. Relapsing viral hepatitis type A. J Med Virol 1985; 16: 163–9
- Sherlock S. The natural history of hepatitis B. Postgrad Med J 1987; 63(Suppl 2)7–11
- Beasley R P. Hepatitis B virus as the etiologic agent in hepatocellular carcinoma—epidemiologic considerations. Hepatology 1982; 2: S21–6
- Stevens C E, Beasley R P, Tsui J, Lee W C. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975; 292: 771–4
- Beasley R P, Trepo C, Stevens C E, Szmuness W. The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol 1977; 105: 94–8
- Beasley R P, Hwang L ‐Y, Lee GC ‐Y, Lan C ‐C, Roan C ‐H, Hwang F ‐Y, et al. Prevention of perinatally transmitted hepatitis B virus infection with hepatitis B immune globulin and hepatitis B vaccine. Lancet 1983; 1: 1099–102
- Wong V CW, Ip H MH, Reesink H W, Neolelie P, Reerink‐Brongers E E, Yeung C Y, et al. Prevention of the HBsAg carrier state in newborn infants and HBeAg by administration of hepatitis B vaccine and hepatitis B immunoglobulin. Lancet 1984; 1: 921–6
- Lo K ‐J, Tsai Y ‐T, Lee S ‐D, Wu T C, Wang J ‐Y, Chen G ‐H, et al. Immunoprophylaxis of infection with hepatitis B virus in infants born to hepatitis B surface antigen‐positive carrier mothers. J Infect Dis 1985; 152: 819–22
- Pongpipat D, Suvatte V, Assateerawatts A. Perinatal transmission of hepatitis B virus in Thailand. Asian Pac J Allergy Immunol 1985; 3: 191–3
- Xu Z ‐Y, Liu C ‐B, Francis D P, Purcell R H, Gun Z ‐L, Duan S ‐C, et al. United States–China cooperative study group on hepatitis B. Prevention of perinatal acquisition of hepatitis B virus carriage using vaccine: preliminary report of a randomized, double‐blind placebo‐controlled and comparative trial. Pediatrics 1985; 76: 713–8
- Ilardi C F, Ying Y Y, Ackerman L V, Elias J M. Hepatitis B surface antigen and hepatocellular carcinoma in the People's Republic of China. Cancer 1980; 46: 1612–6
- Clemens R, Safary A, Hepburn A, Roche C, Stanbury W J, André F E. Clinical experience with an inactivated hepatitis A vaccine. J Infect Dis 1995; 171: S44–9, Suppl
- André F E, Safary A. Summary of clinical findings on Engerix‐B, a genetically engineered yeast‐derived hepatitis B vaccine. Postgrad Med J 1987; 63(Suppl 2)169–78
- Ambrosch F, André F E, Delem A, D'Hondt E, Jonas S, Kunz C, et al. Simultaneous vaccination against hepatitis A and B: results of a controlled study. Vaccine 1992; 10(Suppl 1)S142–5
- Ambrosch F, Widermann G, André F E, Delem A, Gregor H, Hofmann H, et al. Clinical and immunological investigation of a new combined hepatitis A and hepatitis B vaccine. J Med Virol 1994; 44: 452–6
- Hess G, Clemens R, Bienzle U, Schönfeld C, Schunk B, Bock H L. Immunogenicity and safety of an inactivated hepatitis A vaccine in anti‐HIV positive and negative homosexual men. Clinical evaluation of a recombinant hepatitis B vaccine in HIV‐infected vs uninfected persons. J Med Virol 1995; 46: 40–2
- Gesemann M, Scheiermann N, Brockmeyer N, Kreuzfelder E, Safary A, Simoen E, . Viral hepatitis and liver disease, A J Zuckerman, et al. Alan R. Liss, New York 1988; 1076–8
- Hess G, Rossol S, Voth R, Cheatham‐Speth D, Clemens R, Meyer zum Büschenfelde K H. Active immunization of homosexual men using a recombinant hepatitis B vaccine. J Med Virol 1989; 29: 229–31